President Trump Signs Major Women’s Health Executive Order as Melania Unveils New White House Task Force

President Trump signed a sweeping executive order Monday establishing a new federal initiative dedicated to improving women’s health, with First Lady Melania Trump taking a leading role in developing the program.

The president and first lady announced the initiative during a White House Rose Garden ceremony, unveiling plans to expand medical research, accelerate the development of new treatments and improve healthcare for women at every stage of life.

The executive order establishes the first White House Women’s Health Task Force and directs the National Institutes of Health to create a new division focused specifically on women’s health.

Melania Trump described the announcement as a major step toward addressing medical conditions that have historically received insufficient research and attention.

“This is a transformative moment for women in America,” the first lady declared. “Beginning today, we will change the reality of women’s health.”

The initiative reflects months of work by Melania Trump, who has met with federal health officials and medical experts to develop a coordinated strategy for improving women’s healthcare.

President Trump praised his wife’s involvement and described the executive order as an important step toward strengthening medical research and treatment.

The president said the administration intends to expand scientific investigations into conditions affecting women while ensuring that discoveries translate into meaningful improvements in patient care.

The newly established Women’s Health Division will operate within the National Institutes of Health, working alongside the existing Office of Research on Women’s Health.

Federal officials have been directed to establish the division within 90 days.

Its research priorities will include breast cancer, cardiovascular disease, autoimmune disorders, infertility, endometriosis, menopause, osteoporosis, Alzheimer’s disease and other conditions that uniquely or disproportionately affect women.

The division will also examine differences in how diseases affect men and women, with the goal of improving diagnosis, treatment and prevention.

A major component of the initiative involves strengthening the inclusion of women and girls in clinical trials and ensuring that federally funded research adequately accounts for biological differences.

The White House Women’s Health Task Force will coordinate these efforts across multiple federal agencies.

HHS Secretary Robert F. Kennedy Jr. and White House Chief of Staff Susie Wiles will serve as co-chairs.

Wiles recently completed treatment for breast cancer, giving the administration’s chief of staff a personal connection to one of the diseases included in the initiative.

President Trump praised Wiles during the signing ceremony, recognizing her experience and commitment to improving healthcare.

The task force will include senior officials from the Food and Drug Administration, Centers for Disease Control and Prevention, National Institutes of Health and Centers for Medicare and Medicaid Services.

Representatives from additional federal departments will also participate, including agencies responsible for veterans’ affairs, education, labor and environmental protection.

The administration intends for the group to coordinate research priorities and identify opportunities to improve healthcare delivery.

Kennedy emphasized that the initiative will focus on translating scientific discoveries into practical treatments rather than allowing promising research to remain confined to laboratories.

“For generations, women have faced unanswered questions about conditions that uniquely or disproportionately affect them,” Kennedy said.

He explained that the new NIH division will work to improve prevention, diagnosis and treatment through rigorous scientific research.

Melania Trump outlined five priorities that she believes should guide the federal initiative.

Her proposals include directing research funding toward conditions that disproportionately affect women, using advanced technology to accelerate discoveries and reducing the time required to bring promising therapies to patients.

She also emphasized affordability, arguing that medical breakthroughs should be accessible to women regardless of their financial circumstances.

Another priority involves improving education and public discussions surrounding women’s health issues that have historically received limited attention.

The first lady specifically highlighted the potential for artificial intelligence and advanced biotechnology to improve scientific understanding of female biology.

She argued that emerging technologies could help researchers identify new treatments and develop more personalized approaches to healthcare.

The administration’s strategy also includes improving cooperation between government agencies, universities, private companies and medical researchers.

Federal officials believe stronger coordination could help reduce duplication, identify research gaps and accelerate the adoption of effective treatments.

NIH Director Dr. Jay Bhattacharya welcomed the initiative, saying the new division could help answer important medical questions and make better use of federal research investments.

The executive order also directs officials to examine how medical discoveries can be incorporated more quickly into clinical practice.

That emphasis reflects a broader administration goal of connecting federally funded scientific research with measurable improvements in patient outcomes.

The initiative addresses health needs throughout a woman’s life, beginning in childhood and adolescence and continuing through pregnancy, middle age, menopause and aging.

Maternal health and infertility are among the areas receiving additional attention.

The administration has previously announced initiatives involving fertility education, reproductive healthcare and improved access to treatment for menopause symptoms.

Federal health officials have also pursued changes intended to strengthen breast cancer screening and diagnostic follow-up.

The new executive order is designed to coordinate those efforts within a broader federal strategy.

During the ceremony, Melania Trump emphasized that improving women’s health requires both scientific innovation and greater public awareness.

She said medical progress should help women live longer, healthier lives while maintaining their independence and ability to pursue personal goals.

The first lady also stressed that treatments must remain subject to appropriate safety standards as researchers work to accelerate development.

The announcement comes during Breast Cancer Awareness Month, drawing additional attention to the importance of early detection and effective treatment.

Although the executive order establishes new administrative structures and research priorities, it does not specify a new funding amount for the programs.

The financial impact will depend partly on how federal agencies allocate existing resources and what additional investments are authorized.

The task force was scheduled to hold its first working session Monday afternoon in the White House Roosevelt Room.

Its members will begin examining opportunities for cooperation across federal agencies and identifying priorities for future action.

President Trump’s executive order marks a significant expansion of the administration’s stated focus on women’s health, with Melania Trump positioned as a central advocate for the initiative.

The first lady closed her remarks by emphasizing that medical research should ultimately improve the everyday lives of women and girls.

The administration will now begin implementing the order, with the new NIH division expected to be established within three months and the White House task force beginning its work immediately.